Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Challoner: We Recommended FDA Replace 510(k) Clearance
This article is from
The Cancer Letter
archive.
Vol. 40 No. 27 | July 4, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
ASCO Recommends Discussing Pharmacological Prevention
July 26, 2013
TCL Archive
Congress gives FDA authority to require pediatric clinical trials.
November 28, 2003
TCL Archive
Small Business Technology Transfer Program Solicitation
June 23, 1995
TCL Archive
Social Networks Influence Decision To Quit Smoking
May 30, 2008
TCL Archive
Second-Generation CML Drugs Show Promise For Frontline
December 26, 2008
TCL Archive
DCT Board Approves Recompetition Of Drug Development Contracts
June 25, 1993